Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA

Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease

Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases

Commentary on Twitter

In patients w high-risk CVD, high-dose trivalent influenza vaccine, vs standard-dose quadrivalent vaccine, did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations https://t.co/I3XygBajQL

— JAMA (@JAMA_current) December 4, 2020